NI-3501

N/A

Report date: 2025/05/09 15:53:58

Base Information

Drug NameNI-3501
Drug Alias NameNI-3501
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionInterleukin-2 receptor beta chain agonistsInterleukin-2 receptor subunit gamma agonists
TargetsInterleukin-2 receptor beta chainInterleukin-2 receptor subunit gamma
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLight Chain Bioscience Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNovimmune SaLight Chain Bioscience Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A